RxDoctor Payments Data

Oana Pickering, PA

Physician Assistant · San Diego, CANPI 1033735329

Payments from drug & device makers

$1,669in general payments, 2019–2025

Across 58 payments — averaging $28.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$195
  • Gilead$180
  • Novo Nordisk$156
  • Hologic Sales And Service, LLC$136
  • Edwards Lifesciences$134
  • Organon$117
  • plus $752 from 17 others

What the payments were for

  • Food & beverage$1,669100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,669 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$6,958
Medicare patients
34
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$34,638
Atorvastatin Calcium69$743
Ezetimibe18$564
Estradiol (Once Weekly)Estradiol12$559
Sertraline Hcl17$438
Albuterol Sulfate HfaAlbuterol Sulfate23$385
Gabapentin32$352
Levothyroxine Sodium25$313
ClopidogrelClopidogrel Bisulfate18$274
Rosuvastatin Calcium18$174
Famotidine11$162
Tamsulosin Hcl13$159
Pantoprazole Sodium11$146
Losartan Potassium21$126
Lisinopril32$121

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$156$34,63836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →